Brokerages of Wall Street have issued a hold rating on the stocks of ROP- according to the ten investment analysts who have been covering the stocks of the firm. Two of the investment analysts have already issued ROP with a rating of sell- while five of the other analysts prescribed the company with a rating of buy. The price target of the company has been set at $408- calculated over a period of a single year.
The Quarterly Estimate of ROP
There have been quite a few companies that have commented on the stocks of ROP. JPMorgan Chase & Co was the first to reduce the price target from a sum of $320 to $310, along with a rating of underweight in a 1st February research note. Argus has increased the price target of the company from $425 to $440 along with a rating of buy in a Tuesday research report.
Royal Bank of Canada went the other way to decrease the price target of the company from $510 to $479- along with an outperform rating. Zacks Investment Research went from a rating of buy to hold- with a price target set at $386. In the end, Oppenheimer reaffirmed their rating of hold in a 31st January research note.
The stocks of ROP traded on Friday at $404.95. The moving average price of the company over 50 days is $418.59, with the moving average price of the company over 200 days is $415.46. The market cap of the company is $42.47 billion, with a PE ratio of around 27.27, and a 1.03 beta. The current ratio of ROP is 0.73, with a 0.90 debt-to-equity ratio. The year low of the company is $240, along with a year high of around $455.72.
